2024 ASCO® Annual Meeting Insights Hub

Meeting coverage & Vumedi’s exclusive highlights, all in one place.

Sarcoma

706 views 64 hours watched
18:08

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Highlights: Advances in GIST Tumors and Soft Tissue Sarcomas

FEATURING Atif Hussein
  • 224 views
  • August 12, 2024
  • 1
07:57

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Efficacy of Nirogacestat in Patients With Poor Prognostic Factors for Desmoid Tumors - Analyses From the DeFi Study"

FEATURING Bruno Vincenzi
  • 47 views
  • July 25, 2024
16:37

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Highlights in Sarcomas

FEATURING Robin Jones
  • 249 views
  • July 12, 2024
  • 2
02:27

ecancer

ASCO® 2024 Insights: "Monitoring Ovarian Function in DeFi Study - Nirogacestat in Desmoid Tumors"

FEATURING Elizabeth Loggers
  • 38 views
  • June 24, 2024
13:29

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Sorafenib Treatment Duration in Desmoid Tumors"

FEATURING Philippos Costa
  • 68 views
  • June 17, 2024
04:54

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "PROs of the MEDISARC Study (AIO-STS-0415) - Durvalumab & Tremelimumab vs. Doxorubicin in Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma"

FEATURING Viktor Grünwald
  • 80 views
  • June 12, 2024
  • 1